Rare diseases are those that meet a prevalence threshold of not more than five affected persons per 10000, in line with Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products [OJ L 18, 22.1.2000, p. 1.], and they are all serious, chronic and often life threatening. Some patients affected by rare diseases face difficulties in their quest for a diagnosis and treatment to improve their quality of life and to increase their life expectancy, difficulties which were also recognised by the Council Recommendation of 8 June 2009 on an action in the field of rare diseases [OJ C 151, 3.7.2009, p. 7.].
Recital 55, Directive (EU) 2011/24
In forcesince 9 Mar 2011